Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222

Objective: To determine whether severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibody levels after the first dose of vaccine can predict the final antibody response, and whether this is dependent on the vaccine type. Methods: Sixty-nine recipients of BNT162b2 (Pfizer/BioNTech) and 55...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Infect Dis
Glavni autori: Perkmann, Thomas, Perkmann-Nagele, Nicole, Mucher, Patrick, Radakovics, Astrid, Repl, Manuela, Koller, Thomas, Jordakieva, Galateja, Wagner, Oswald F., Binder, Christoph J., Haslacher, Helmuth
Format: Artigo
Jezik:Inglês
Izdano: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8317449/
https://ncbi.nlm.nih.gov/pubmed/34332084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2021.07.063
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items